19 October 2025 -- Georgia, US -- At the annual IDWeek meeting, Bruker announced the U.S. Food and Drug Administration (FDA) clearance of Claim 7 and Claim 8 for its MALDI Biotyper CA System, marking a significant advancement in clinical microbial identification capabilities.

13 October 2025 -- Basel, Switzerland -- ACD/Labs, an informatics company that develops and commercializes software in support of R&D, and Covestro, a global leader in high-performance polymers, have joined forces to bring AI-powered solvent recommendation capabilities to the Percepta platform.

13 October 2025 -- Birmingham, UK -- Medical innovation in the West Midlands has taken a major step forward thanks to the arrival of the Boston Micro Fabrication (BMF) microArch S240 at PHTA – a pioneering micro-precision 3D printer designed for short-run industrial production and advanced life sciences R&D

9 October 2025 -- Lausanne, Switzerland and Maryland, US -- Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS Spheroid DRUG-seq, a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models

7 October 2025 -- Liege, Belgium -- Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, today announces new research showing superior shock-absorbing capacities of its Hydrocelin injectable hydrogel to treat osteoarthritis, compared to four market leading hydrogels.

7 October 2025 -- Tokyo, Japan -- MOLCURE Inc. today announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative antibody therapeutics for multiple targets using MOLCURE’s proprietary AI-driven platform technology.

2 October 2025 -- Texas, US and Copenhagen, Denmark -- The START Center for Cancer Research, its preclinical division XenoSTART, and Minerva Imaging today announced an expansion of their decade-long partnership to establish the industry’s most comprehensive integrated platform for radiopharmaceutical drug development.

2 October 2025 -- Kufstein, Austria -- Single Use Support has officially received the ISO 27001:2022 certification by Quality Austria, with international recognition through IQNET. This certification independently confirms that the company has successfully implemented and maintains a comprehensive Information Security Management System across its sites in Kufstein and Hall, meeting globally recognized standards for data protection and operational security.

2 October 2025 -- Fukuoka, Japan -- Tres Alchemix, an early-stage biotechnology company applying artificial intelligence (AI) to drug discovery, today announced it has closed a $4.4 million [¥650 million] Series A financing. The round was led by DNX Ventures, with participation from existing investor Waseda University Ventures.

1 October 2025 -- Missouri, US -- Likarda, a global leader in complex therapy formulation for cell and large-molecule therapeutics, today announced the launch of Predictive Polymer Analytics (PPA), its next-generation artificial intelligence (AI) platform designed to radically accelerate and de-risk the formulation design process for clients developing advanced therapeutics.

1 October 2025 -- California, US and Seoul, South Korea -- Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, and Gencurix, Inc, a leading Korean developer of oncology testing solutions, today announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe.

30 September 2025 -- Massachusetts, US -- Elemental Machines, a pioneer in intelligent lab operations solutions, announced it has been recognized in the latest Gartner Hype Cycle for the Internet of Things, 2025 report. This report evaluates innovations and trends impacting Internet of Things leaders.